5 research outputs found
Simple and fast HPLC method for simultaneous determination of retinol, tocopherols, coenzyme Q10 and carotenoids in complex samples
International audienceThe effects of fat-soluble vitamins (such as vitamins A and E) and lipid microconstituents (such as carotenoids) on human health are now well established. However, high-performance liquid chromatography (HPLC) methods able to detect these molecules in simultaneous runs are often difficult to set up. We report here a 35-min reversed-phase HPLC method using a single C30 column kept at 35 degrees C with a gradient system of methanol, methyl-tert-butyl ether and water at a flow-rate of 1 mL/min. This method resolves 11 carotenoids, retinol, alpha- and gamma-tocopherol from complex matrixes such as food samples, human plasma and human adipose tissue within 35 min. The method is also able to separate coenzyme Q(10). The intra-day and inter-day coefficients of variation are suitable for routine clinical and scientific applications for the determination of lipid micronutrients from various sample types
In vitro and ex vivo metabolism of diallyl disulfide, a characteristic sulfur compound of garlic, in rat.
International audienc
Cholesterol-lowering effect of non-viscous soluble dietary fiber NUTRIOSE (R) 6 in moderately hypercholesterolemic hamsters
International audienceNUTRIOSE (R) 6 is a new wheat starch-based low-digestible carbohydrate. This study investigated the effect of this soluble non-viscous fiber on cholesterol metabolism. Hamsters fed with 0.25% cholesterol-enriched diet (CHO) were given graded amounts of NUTRIOSE (R) 6, i.e. 0% (cellulose, CHO), 3% (N3), 6% (N6) or 9% (N9) (w:w). As compared to CHO diet, 9% NUTRIOSE (R) 6 significantly lowered plasma and LDL cholesterol by 14.5 and 23.8%, respectively. The LDL-cholesterol lowering effect was also significant with the 6% dose (-21.4%). NUTRIOSE (R) 6 diets prevented hepatic cholesterol accumulation (-10 to -20%) and significantly decreased bile cholesterol (-47 to -68%) and phospholipids (-30 to -45%) concentrations. The 9% NUTRIOSE (R) 6 diet significantly decreased the rate of dietary cholesterol absorption (-25%) and markedly stimulated faecal neutral sterol (+81%) and bile salts (+220%) excretion. No significant change in cholesterol 7-alpha-hydroxylase or LDL-receptor activities was observed whereas 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity was reduced by 29%. Reduced cholesterol and bile salt absorptions and lowered cholesterol synthesis are likely mechanisms underlying the cholesterol lowering effect of NUTRIOSE (R) 6. Results suggest the use of NUTRIOSE (R) 6 as a new dietary cholesterol-lowering agent that should be tested in humans as treatment and evenly prevention of mild hypercholesterolemia
Cholesterol-lowering effect of non-viscous soluble dietary fiber NUTRIOSE<sup>®</sup>6 in moderately hypercholesterolemic hamsters
219-228NUTRIOSE®6
is a new wheat starch-based low-digestible carbohydrate. This study
investigated the effect of this soluble non-viscous fiber on cholesterol
metabolism. Hamsters fed with 0.25% cholesterol-enriched diet (CHO) were given
graded amounts of NUTRIOSE®6, i.e. 0% (cellulose, CHO), 3% (N3), 6%
(N6) or 9% (N9) (w:w). As compared to CHO diet, 9% NUTRIOSE®6
significantly lowered plasma and LDL cholesterol by 14.5 and 23.8%, respectively.
The LDL-cholesterol lowering effect was also significant with the 6% dose
(-21.4%). NUTRIOSE®6 diets prevented hepatic cholesterol
accumulation (-10 to -20%) and significantly decreased bile cholesterol (-47 to
-68%) and phospholipids (-30 to -45%) concentrations. The 9% NUTRIOSE®6
diet significantly decreased the rate of dietary cholesterol absorption (-25%)
and markedly stimulated faecal neutral sterol (+81%) and bile salts (+220%)
excretion. No significant change in cholesterol 7-a-hydroxylase or LDL-receptor
activities was observed whereas 3-hydroxy-3-methylglutaryl-coenzyme A reductase
activity was reduced by 29%. Reduced cholesterol and bile salt absorptions and
lowered cholesterol synthesis are likely mechanisms underlying the cholesterol
lowering effect of NUTRIOSE®6. Results suggest the use of NUTRIOSE®6
as a new dietary cholesterol-lowering agent that should be tested in humans as
treatment and evenly prevention of mild hypercholesterolemia